Dr Jinu M Mathew, DPT | |
1034 N Rohlwing Rd, Addison, IL 60101-1034 | |
(630) 967-2000 | |
(708) 226-7196 |
Full Name | Dr Jinu M Mathew |
---|---|
Gender | Male |
Speciality | Physical Therapist |
Location | 1034 N Rohlwing Rd, Addison, Illinois |
Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
Identifier | Type | State | Issuer |
---|---|---|---|
1588430425 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
225100000X | Physical Therapist | 070.027960 (Illinois) | Primary |
Provider Name | Dupage Medical Group Ltd |
---|---|
Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
Provider Identifiers | NPI Number: 1801833983 PECOS PAC ID: 5496667941 Enrollment ID: O20040116000661 |
News Archive
Scientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein's levels might someday help prevent muscle loss caused by cancer, prolonged inactivity in hospital patients, and aging.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid Drug Platform.
New research suggests the use of hookah steam stones - commonly considered a safer alternative to cigarette smoking - could be leaving users with a dangerous, false sense of security. The findings out of the University of Cincinnati/Agilent Technologies Metallomics Center of the Americas are published this month in the Microchemical Journal.
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Jinu M Mathew, DPT Po Box 713260, Chicago, IL 60677-1260 Ph: (630) 469-9200 | Dr Jinu M Mathew, DPT 1034 N Rohlwing Rd, Addison, IL 60101-1034 Ph: (630) 967-2000 |
News Archive
Scientists at Dana-Farber Cancer Institute have isolated a previously unknown protein in muscles that spurs their growth and increased power following resistance exercise. They suggest that artificially raising the protein's levels might someday help prevent muscle loss caused by cancer, prolonged inactivity in hospital patients, and aging.
UK-based contract research organisation Selcia Limited and Swedish drug development company NeuroVive Pharmaceutical AB have signed a significant research collaboration agreement to develop new medicines and drug compounds targeting mitochondrial physiology and pathophysiology.
Santaris Pharma A/S, a privately held biopharmaceutical company focused on developing medicines targeted to disease-related mRNAs and microRNAs, today announced a worldwide strategic alliance with Bristol-Myers Squibb to discover and develop novel medicines using Santaris Pharma's proprietary Locked Nucleic Acid Drug Platform.
New research suggests the use of hookah steam stones - commonly considered a safer alternative to cigarette smoking - could be leaving users with a dangerous, false sense of security. The findings out of the University of Cincinnati/Agilent Technologies Metallomics Center of the Americas are published this month in the Microchemical Journal.
Baxter International Inc. today confirmed that the European Commission (EC) has granted marketing authorization for CELVAPAN H1N1 pandemic vaccine using Baxter's Vero cell technology. CELVAPAN H1N1 is the first cell culture-based and non-adjuvanted pandemic influenza vaccine to receive marketing authorization in the European Union.
› Verified 1 days ago
Dr. Timothy Robert Gibbons, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1841 W Army Trail Rd, Addison, IL 60101 Phone: 630-238-9235 | |
Jennifer Alcedo, PT Physical Therapist Medicare: Medicare Enrolled Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 Fax: 630-766-0855 | |
Crystal Wright, PTA Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 2171 W Executive Dr Ste 500, Addison, IL 60101 Phone: 630-766-0505 | |
Marzena D Kaniuk, PT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 1415 W Lake St, Addison, IL 60101 Phone: 866-644-8040 Fax: 630-705-1980 | |
Adam E Brhel, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1776 W Centennial Pl, Addison, IL 60101 Phone: 630-953-0343 Fax: 630-953-0353 | |
Jane Soo Eun, MPT Physical Therapist Medicare: Medicare Enrolled Practice Location: 500 W Lake St, Addison, IL 60101 Phone: 630-607-1820 Fax: 630-628-5307 | |
Gazanfer Mushtaq, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 1776 W Centennial Pl, Addison, IL 60101 Phone: 630-953-0343 Fax: 630-953-0353 |